Improving Measurement Of Parents' Understanding Of Research Permission

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2013 by University of Rochester
Sponsor:
Information provided by (Responsible Party):
University of Rochester
ClinicalTrials.gov Identifier:
NCT01704560
First received: October 4, 2012
Last updated: January 8, 2013
Last verified: January 2013
  Purpose

Well-informed potential subjects are presumably better able to make autonomous decisions about the risks and benefits of participating in a research study than those in possession of less information. In actuality, prior research into consent understanding suggests that longer forms offering exhaustive information may inhibit rather than promote understanding. Moreover, technical wording in tools used to measure parent understanding of research permission may also lead to inhibition of understanding. This study will test the hypothesis that, among parents of potential subjects for greater-than-minimal-risk research, two modified and simplified subset of questions from the Deaconess Informed Consent Comprehension Test (DICCT), one oral and open-ended and one written and multiple choice, will increase subject understanding of the nature and risks of the research. The study will enroll the parents of 40 potential neonatal research subjects with an interim analysis of data at 20 subjects. Subjects will review a sham research permission form and will be randomized 1:1 to complete one of the two modified comprehension tests in addition to the DICCT (gold-standard) test. Parents will be given an open-ended survey after the tests in order to qualitatively describe their opinions of each test. A subset of parents who have received the written form will also undergo a cognitive interview about the form. A similar subset will also be given an open-ended survey about a proposed permission form cover sheet. The primary outcome will be the correlation of scores between the DICCT and modified comprehension tests, following the sham informed consent process.


Condition Intervention
Focus of the Study is to Improve Parents' Understanding of Research Permission.
Other: Coversheet to Informed Consent

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: IMPROVING MEASUREMENT OF PARENTS' UNDERSTANDING OF RESEARCH PERMISSION

Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • DICCT Questionnaire [ Time Frame: Within 2 weeks after being approached for participation. ] [ Designated as safety issue: No ]

    Score on the post-permission DICCT questionnaire. The DICCT is scored on a 28 point scale, with each of 14 parameters being scored as 0 = incorrect, 1 = partially correct, 2 = correct. The DICCT, in addition to being previously validated, has other advantages. It contains questions that are not directly addressed in the cover sheet, but addressed in the full permission form, such as compensation for injury. These items will serve as valuable internal controls. The DICCT is easily adaptable to written answers, which makes it ideal for further modification in future studies.

    The DICCT will be administered during a structured interview, without a time limit. The parent will be allowed to refer to the permission form to answer the questions.



Estimated Enrollment: 40
Study Start Date: March 2012
Estimated Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Coversheet to Informed Consent
Coversheet attached to Informed Consent.
Other: Coversheet to Informed Consent
The intervention is a one page cover sheet to be affixed to the front of the standard permission form for the trial for which permission is being sought (attached to application). The form will identify the study as research and contain sections that include investigator contact information, the purpose of the study, a brief description of the study procedures, the alternatives, the voluntary nature, the risks, the potential benefits, a discussion of privacy and confidentiality, the costs and the payments. Each topic will also contain a reference to the page in the consent containing the full description of the topic. The form is designed to have a reading level no higher than 6th to 8th grade. Parents will also receive the full permission form, and all required signatures will still be collected on the permission form.
No Intervention: No Coversheet
Standard, full permission form, without the coversheet.

  Eligibility

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parents of potential subjects eligible for a NICHD Neonatal Research Network (NRN) interventional trial ("Hydrocortisone/Extubation") or greater-than-minimal risk observational trial ("PROP")
  • Permission being sought for a qualifying study
  • English speaking

Exclusion Criteria:

  • Permission has not been previously sought for another qualifying study
  • Illiteracy (unable to read simple forms)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01704560

Locations
United States, New York
Women and Children's Hospital of Buffalo Not yet recruiting
Buffalo, New York, United States, 14222
Contact: Ashley M Williams, M.S.Ed    716-878-7140    mailto:awilliams@upa.chob.edu   
Principal Investigator: Satyan Lakshminrusimha, MD         
Sub-Investigator: Anne Marie Reynolds, MPH, MD         
University of Rochester Medical Center Recruiting
Rochester, New York, United States, 14692
Contact: Julianne E Hunn, BA    585-276-6450    julianne_hunn@urmc.rochester.edu   
Principal Investigator: Carl T D'Angio, MD         
Sub-Investigator: Gloria S Pryhuber, MD         
Sub-Investigator: Patricia R Chess, MD         
Sub-Investigator: Hongyue Wang, PhD         
Sub-Investigator: Laura Shone, MSW, DrPH         
Sponsors and Collaborators
University of Rochester
Investigators
Principal Investigator: Carl T D'Angio, MD University of Rochester
  More Information

No publications provided

Responsible Party: University of Rochester
ClinicalTrials.gov Identifier: NCT01704560     History of Changes
Other Study ID Numbers: 39377
Study First Received: October 4, 2012
Last Updated: January 8, 2013
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on September 30, 2014